AF
NBIX icon

Allworth Financial’s Neurocrine Biosciences NBIX Stock Holding History

Allworth Financial’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Buy
14,853
+6,346
+75% +$942K 0.01% 476
2026
Q1 		$1.12M Buy
8,507
+2,068
+32% +$274K ﹤0.01% 675
2025
Q4 		$913K Buy
6,439
+1,430
+29% +$207K ﹤0.01% 728
2025
Q3 		$703K Buy
5,009
+2,029
+68% +$275K ﹤0.01% 766
2025
Q2 		$375K Buy
2,980
+2,845
+2,107% +$326K ﹤0.01% 929
2025
Q1 		$14.3K Sell
135
-31
-19% -$3.93K ﹤0.01% 2268
2024
Q4 		$24.4K Buy
166
+30
+22% +$3.71K ﹤0.01% 1969
2024
Q3 		$15.7K Sell
136
-98
-42% -$13.4K ﹤0.01% 2055
2024
Q2 		$34.1K Buy
234
+146
+166% +$20K ﹤0.01% 1559
2024
Q1 		$12.1K Hold
88
– – ﹤0.01% 2025
2023
Q4 		$11.6K Buy
88
+32
+57% +$3.68K ﹤0.01% 1924
2023
Q3 		$6.3K Sell
56
-19
-25% -$2K ﹤0.01% 2012
2023
Q2 		$7.07K Sell
75
-2
-3% -$195 ﹤0.01% 1971
2023
Q1 		$7.79K Buy
77
+25
+48% +$2.6K ﹤0.01% 1879
2022
Q4 		$6.21K Sell
52
-1
-2% -$117 ﹤0.01% 1824
2022
Q3 		$6K Buy
53
+25
+89% +$2.54K ﹤0.01% 1827
2022
Q2 		$3K Buy
28
+9
+47% +$831 ﹤0.01% 1914
2022
Q1 		$2K Sell
19
-88
-82% -$7.46K ﹤0.01% 1805
2021
Q4 		$9K Sell
107
-17
-14% -$1.56K ﹤0.01% 1410
2021
Q3 		$12K Buy
+124
New +$11.7K ﹤0.01% 1229

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Allworth Financial's NBIX Position: Q2 2026 in Review

Allworth Financial increased its Neurocrine Biosciences (NBIX) stake by 75% in Q2 2026, buying an estimated $942K and bringing the position to 14,853 shares worth $2.5M. The position accounts for 0.01% of the portfolio, ranked #476.

Allworth Financial first reported a position in NBIX in Q3 2021 and has held it in 20 quarters since. 772 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Allworth Financial held 14,853 shares of Neurocrine Biosciences worth $2.5M as of Q2 2026.
  • Allworth Financial bought 6,346 Neurocrine Biosciences shares in Q2 2026, an estimated $942K.
  • Neurocrine Biosciences made up 0.01% of Allworth Financial's portfolio in Q2 2026, its #476 holding.
  • Allworth Financial first reported a position in Neurocrine Biosciences in Q3 2021 and has held it in 20 quarters since.
  • 772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.